Team:Northwestern/Project

From 2012.igem.org

(Difference between revisions)
(added execution/implementation of the plan)
m
 
(12 intermediate revisions not shown)
Line 16: Line 16:
</div>
</div>
<!--abstract-->
<!--abstract-->
-
<p>Iron deficiency affects 2 billion people - or over 30% of the world’s population – and can lead to anemia, ill health, and even death. Surprisingly, this deficiency is typically not due to a lack of dietary iron, but rather due to low bio-availability, and thus poor absorption of iron. Phytic acid is a prevalent chelator of iron and other nutrients in food. Our mission is to build a system that breaks down phytic acid in the digestive system, releasing bound iron for the body to absorb. Our solution comprises two engineered components: a module that constitutively produces phytase to break down phytic acid and a pH-sensitive module that causes cells to lyse and release the accumulated phytase in the stomach. If successful, our strain would be a low-cost sustainable solution to preventing iron deficiency without the need for constant supplies of iron supplements.
+
<p>Iron deficiency affects 2 billion people -or over 30% of the world’s population – and can lead to anemia, ill health, and even death <a href="https://2012.igem.org/Team:Northwestern/Project#cite1">[1]</a>. Surprisingly, this deficiency is typically not due to a lack of dietary iron, but rather due to low bio-availability, and thus poor absorption of iron. Phytic acid is a prevalent chelator of iron and other nutrients in food. Our mission is to build a system that breaks down phytic acid in the digestive system, releasing bound iron for the body to absorb. Our solution comprises two engineered components: a module that constitutively produces phytase to break down phytic acid and a pH-sensitive module that causes cells to lyse and release the accumulated phytase in the stomach. If successful, our strain would be a low-cost sustainable solution to preventing iron deficiency without the need for constant supplies of iron supplements.
 +
 
</div>
</div>
 +
 +
<div class="content">
 +
<div style="margin-left:auto; margin-right:auto; width: 900px; height:500px">
 +
 +
<img src="https://static.igem.org/mediawiki/2012/1/19/Untitled-1.png" style="border:10px solid #333">
 +
<img src="https://static.igem.org/mediawiki/2012/d/dc/Untitled-2.png" style="border:10px solid #333; float:right">
 +
 +
</div>
 +
</div>
 +
 +
<div class="content">
<div class="content">
Line 26: Line 38:
<p>Our team focused on ameliorating nutrient deficiencies in developing countries. The three main nutrient deficiency disorders listed by the World Health Organization are vitamin A deficiency (VAD), iodine deficiency disorder (IDD) and iron deficiency anemia (IDA). We chose to focus on iron deficiency anemia, which is "the most common and widespread nutritional disorder in the world."
<p>Our team focused on ameliorating nutrient deficiencies in developing countries. The three main nutrient deficiency disorders listed by the World Health Organization are vitamin A deficiency (VAD), iodine deficiency disorder (IDD) and iron deficiency anemia (IDA). We chose to focus on iron deficiency anemia, which is "the most common and widespread nutritional disorder in the world."
-
<p><a href="http://www.chalmers.se/chem/EN/divisions/food-science/research">Research has been done in low-income countries</a> to demonstrate that iron deficiency is not a result a lack of iron in the diet, but rather a lack of bioavailability of the iron within the diet. The lack of bioavailability is due to phytate chelating the iron into a state that the body cannot absorb. Phytate (or phytic acid) <a href="http://en.wikipedia.org/wiki/Phytate">is the principal form of storage of phosphorous in many plant tissues.</a>  
+
<p>Research in low-income countries has demonstrated that iron deficiency arises not from a lack of iron in the diet, but rather from low bioavailability of iron in the diet. Low bioavailability is due to phytate-mediated chelation of iron in a state that the body cannot absorb. Indeed, phytate (or phytic acid) is a major component of plant tissue; it is the principal form of storage of phosphorous in many plants including grains and legumes <a href="https://2012.igem.org/Team:Northwestern/Project#cite2">[2]</a><a href="https://2012.igem.org/Team:Northwestern/Project#cite3">[3]</a><a href="https://2012.igem.org/Team:Northwestern/Project#cite4">[4]</a>. This suggests that iron could be made more readily available without a change in diet by simply dechelating the iron (and other nutrients) from the phytate.
 +
 
 +
<p>Phytase is an enzyme produced by bacteria and fungi that breaks down phytate. <b>Our goal is to produce a probiotic that will release phytase into the body, thus increasing the bioavailability of iron.</b> Since many communities that experience a high prevalence of iron deficiency already use fermented dairy products as part of their diet <a href="https://2012.igem.org/Team:Northwestern/Project#cite5">[5]</a>, our strategy is designed to facilitate implementation in the field by incorporating our engineered probiotic into an existing and accepted cultural practice.
 +
 
-
<p>Phytase is an enzyme produced by bacteria and fungi that breaks down phytic acid. <b>We plan on producing a probiotic that will release phytase into the body, thus increasing the bioavailability of iron.</b>
 
</div>
</div>
Line 37: Line 51:
     <p class="arrow-header">Execution
     <p class="arrow-header">Execution
</div>
</div>
-
<h2>Engineering E. coli to produce phytase</h2>
+
<h3>Engineering E. coli to produce phytase:</h3>
-
<p><a href="http://mic.sgmjournals.org/content/144/6/1565.short">Many organisms</a> produce many different forms of phytase, including <a href="http://www.sciencedirect.com/science/article/pii/S0960852400001395">E. coli</a>. Although E. coli natively produces phytase, we planned on contitutively producing the phytase at a higher rate than in the native cell. Different phytases from different organisms also produce different forms of phytase, each which may be more or less effective at hydrolyzing phytate at different pHs.  
+
<p>Many organisms produce different forms of phytase, including E. coli <a href="https://2012.igem.org/Team:Northwestern/Project#cite7">[7]</a><a href="https://2012.igem.org/Team:Northwestern/Project#cite8">[8]</a>. Although E. coli natively produces phytase, our engineered probiotic concept requires producing the phytase at a higher-than-native level, and selective release of this enzyme into the extracellular environment. Different phytases from different organisms also produce different types of phytases, each of which varies in the rate at which it hydrolyzes phytate as a function of pH.
-
<p>We decided to attempt to clone four different types of phytase from four different organisms: <i>E. coli</i>, <i>Aspergillus niger</i>, <i>Bacillus subtilis </i>, and <i>Citrobacter braakii</i>. We would clone each out of their respective genome with colony PCR, and the ligate the gene into a Biobrick standard backbone.  
+
<p>We sought to clone four different types of phytase from four different organisms: <i>E. coli</i>, <i>Aspergillus niger</i>, <i>Bacillus subtilis</i>, and <i>Citrobacter braakii</i>. Our aim was to create new synthetic biology parts by cloning each into a Biobrick standard backbone, including constructs in which each phytase is expressed from a constitutive promoter.
-
<h2>Method of protein release</h2>
+
<h3>Method of protein release:</h3>
-
<p>The probiotic we are constructing is intended to be activated at a pH from 1.35 to 3.5 that is specific to the stomach. The probiotic is designed to reside in the stomach and selectively lyse the cloned cells to release the phytase. Despite the fact that E.coli is commonly used for recombinant protein production, its secretion capabilities are rather limited. Thus, it was necessary to utilize cell disruption techniques to procure the intracellularly expressed protein of interest. In order to program cell death, while ensuring minimal cell disruption, it was apt to implement bacterial cell lysis, a technique that can successfully lyse cells through intracellular expression of lytic proteins native to the phage.
+
<p>Our strategy is to engineer a probiotic that lyses and releases pre-synthesized phystase only when the probiotic is exposed to the acidic environment of the stomach (pH ~1.35-3.5), since release of iron from phytate in the stomach would enable optimal uptake of this now bioavailable iron. Although E. coli is commonly used for recombinant protein production, its secretion capabilities are finite, and we desire a system in which large quantities of phytase are released quickly before the probiotic and food exit the stomach. Thus, we decided to utilize inducible cell disruption to release pre-synthesized, intracellularly expressed phytase. In order to achieve rapid and conditional disruption via cell death, while ensuring minimal cell disruption prior to the induction of this death program, we decided to utilize bacterial cell lysis induced via intracellular expression of lytic proteins derived from a bacteriophage.
-
<p>In literature, several genetic parts for programmed cell lysis have been studied, including inducible lysis systems. In an inducible lysis system, the T4 phage holin and T7 phage lysozyme genes have been used to produce lytic E.coli strains. Holin is responsible for forming pores in the inner membrane of bacteria, while lysozyme breaks down the peptidoglycan layer and lyzes the cell. Meanwhile, anti-holin is constitutively expressed and it prevents holin from spontaneously allowing lysis. Anti-holin was an imperative part of the construct because ideal lytic systems should be display predictable behavior, instead of randomly lysing at times.  
+
<p>To meet this need, we utilized UC Berkeley’s Lysis Device part (from iGEM 2008), which is very well-characterized on their wiki here <a href="https://2012.igem.org/Team:Northwestern/Project#cite9">[9]</a>. In this inducible lysis system, holin from bacteriophage T4 and lysozyme from bacteriophage T7 are used to produce autolytic E. coli strains. Holin is responsible for forming pores in the inner membrane of bacteria, while lysozyme breaks down the peptidoglycan layer and lyses the cell. Prior to the induction of this death program, anti-holin is constitutively expressed and prevents holin from mediating lysis. Anti-holin is essential for meeting our needs, because preventing lysis should maximize replication of our engineered probiotic during the production phase (e.g., during fermentation of the dairy product) and thereby maximize delivery of phytase cargo to the desired location (the stomach).
</div>
</div>
 +
<div class=content>
 +
<p>Sources:
 +
<ol>
 +
<li> <a id="cite1"><a href="http://www.who.int/nutrition/topics/ida/en/index.html">http://www.who.int/nutrition/topics/ida/en/index.html</a></a></li>
 +
<li> <a id="cite2"><a href="http://www.chalmers.se/chem/EN/divisions/food-science/research">http://www.chalmers.se/chem/EN/divisions/food-science/research</a></a></li>
 +
<li> <a id="cite3"><a href="http://en.wikipedia.org/wiki/Phytic_acid">http://en.wikipedia.org/wiki/Phytic_acid</a></a> </li>
 +
<li> <a id="cite4"><a href="http://en.wikipedia.org/wiki/Phytate">http://en.wikipedia.org/wiki/Phytate</a></a></li>
 +
<li> <a id="cite5"><a href="http://www.sciencedirect.com/science/article/pii/S1360138501021045">http://www.sciencedirect.com/science/article/pii/S1360138501021045</a></a> </li>
 +
<li> <a id="cite6"><a href="http://www.benthamscience.com/cnf/sample/cnf3-1/D0007NF.pdf">http://www.benthamscience.com/cnf/sample/cnf3-1/D0007NF.pdf</a></a> </li>
 +
<li> <a id="cite7"><a href="http://mic.sgmjournals.org/content/144/6/1565.short">http://mic.sgmjournals.org/content/144/6/1565.short</a></a></li>
 +
<li> <a id="cite8"><a href="http://www.sciencedirect.com/science/article/pii/S0960852400001395">http://www.sciencedirect.com/science/article/pii/S0960852400001395</a></a></li>
 +
<li> <a id="cite9"><a href=”https://2008.igem.org/Team:UC_Berkeley/LysisDevice”>https://2008.igem.org/Team:UC_Berkeley/LysisDevice</a></a></li>
 +
 +
</ol>
</div>
</div>
 +
 +
</div>
 +
 +
</html>
</html>

Latest revision as of 01:49, 27 October 2012

Phytase Probiotic

Abstract

Iron deficiency affects 2 billion people -or over 30% of the world’s population – and can lead to anemia, ill health, and even death [1]. Surprisingly, this deficiency is typically not due to a lack of dietary iron, but rather due to low bio-availability, and thus poor absorption of iron. Phytic acid is a prevalent chelator of iron and other nutrients in food. Our mission is to build a system that breaks down phytic acid in the digestive system, releasing bound iron for the body to absorb. Our solution comprises two engineered components: a module that constitutively produces phytase to break down phytic acid and a pH-sensitive module that causes cells to lyse and release the accumulated phytase in the stomach. If successful, our strain would be a low-cost sustainable solution to preventing iron deficiency without the need for constant supplies of iron supplements.

Purpose

Our team focused on ameliorating nutrient deficiencies in developing countries. The three main nutrient deficiency disorders listed by the World Health Organization are vitamin A deficiency (VAD), iodine deficiency disorder (IDD) and iron deficiency anemia (IDA). We chose to focus on iron deficiency anemia, which is "the most common and widespread nutritional disorder in the world."

Research in low-income countries has demonstrated that iron deficiency arises not from a lack of iron in the diet, but rather from low bioavailability of iron in the diet. Low bioavailability is due to phytate-mediated chelation of iron in a state that the body cannot absorb. Indeed, phytate (or phytic acid) is a major component of plant tissue; it is the principal form of storage of phosphorous in many plants including grains and legumes [2][3][4]. This suggests that iron could be made more readily available without a change in diet by simply dechelating the iron (and other nutrients) from the phytate.

Phytase is an enzyme produced by bacteria and fungi that breaks down phytate. Our goal is to produce a probiotic that will release phytase into the body, thus increasing the bioavailability of iron. Since many communities that experience a high prevalence of iron deficiency already use fermented dairy products as part of their diet [5], our strategy is designed to facilitate implementation in the field by incorporating our engineered probiotic into an existing and accepted cultural practice.

Execution

Engineering E. coli to produce phytase:

Many organisms produce different forms of phytase, including E. coli [7][8]. Although E. coli natively produces phytase, our engineered probiotic concept requires producing the phytase at a higher-than-native level, and selective release of this enzyme into the extracellular environment. Different phytases from different organisms also produce different types of phytases, each of which varies in the rate at which it hydrolyzes phytate as a function of pH.

We sought to clone four different types of phytase from four different organisms: E. coli, Aspergillus niger, Bacillus subtilis, and Citrobacter braakii. Our aim was to create new synthetic biology parts by cloning each into a Biobrick standard backbone, including constructs in which each phytase is expressed from a constitutive promoter.

Method of protein release:

Our strategy is to engineer a probiotic that lyses and releases pre-synthesized phystase only when the probiotic is exposed to the acidic environment of the stomach (pH ~1.35-3.5), since release of iron from phytate in the stomach would enable optimal uptake of this now bioavailable iron. Although E. coli is commonly used for recombinant protein production, its secretion capabilities are finite, and we desire a system in which large quantities of phytase are released quickly before the probiotic and food exit the stomach. Thus, we decided to utilize inducible cell disruption to release pre-synthesized, intracellularly expressed phytase. In order to achieve rapid and conditional disruption via cell death, while ensuring minimal cell disruption prior to the induction of this death program, we decided to utilize bacterial cell lysis induced via intracellular expression of lytic proteins derived from a bacteriophage.

To meet this need, we utilized UC Berkeley’s Lysis Device part (from iGEM 2008), which is very well-characterized on their wiki here [9]. In this inducible lysis system, holin from bacteriophage T4 and lysozyme from bacteriophage T7 are used to produce autolytic E. coli strains. Holin is responsible for forming pores in the inner membrane of bacteria, while lysozyme breaks down the peptidoglycan layer and lyses the cell. Prior to the induction of this death program, anti-holin is constitutively expressed and prevents holin from mediating lysis. Anti-holin is essential for meeting our needs, because preventing lysis should maximize replication of our engineered probiotic during the production phase (e.g., during fermentation of the dairy product) and thereby maximize delivery of phytase cargo to the desired location (the stomach).